Rethinking the Amyloid Hypothesis: New Perspectives in Alzheimer's Research - PRESS AI WORLD
PRESSAI
Science

Rethinking the Amyloid Hypothesis: New Perspectives in Alzheimer's Research

share-iconPublished: Saturday, January 11 share-iconUpdated: Saturday, January 11 comment-icon10 months ago
News sources:
SALON
Rethinking the Amyloid Hypothesis: New Perspectives in Alzheimer's Research

Credited from: SALON

  • Alzheimer’s disease is expected to affect 153 million adults globally by 2050, prompting urgent research and therapeutic development.
  • The amyloid cascade hypothesis, linking amyloid beta protein to Alzheimer’s, has faced criticism and controversies surrounding drug approvals and safety.
  • The FDA's approval of drugs like aducanumab was controversial due to mixed trial data, with concerns over safety risks such as brain swelling.
  • Recent research suggests that while amyloid may play a role in the disease, it is likely not the sole factor driving its progression.
  • The future of Alzheimer’s treatments may involve a multi-faceted approach, incorporating insights from immune responses and other factors linked to neurodegeneration.

For the full article, visit here.

SHARE THIS ARTICLE:

nav-post-picture
nav-post-picture